Perioperative bridging with fondaparinux in a woman with antithrombin deficiency.
Bauersachs
Rupert
R
Alban
Susanne
S
D000925:Anticoagulants / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D065427:Factor Xa Inhibitors; D005260:Female; D005337:Fibrin / Q000172:deficiency* / Q000235:genetics; D000077425:Fondaparinux; D006801:Humans; D008875:Middle Aged; D019990:Perioperative Care; D010644:Phenprocoumon / Q000627:therapeutic use; D011134:Polysaccharides / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D019106:Postoperative Hemorrhage / Q000139:chemically induced; D013514:Surgical Procedures, Operative; D013923:Thromboembolism / Q000209:etiology / Q000517:prevention & control*; D019851:Thrombophilia / Q000097:blood / Q000150:complications / Q000188:drug therapy*; D020246:Venous Thrombosis / Q000209:etiology / Q000517:prevention & control*; D014812:Vitamin K / Q000037:antagonists & inhibitors
D000925:Anticoagulants; D065427:Factor Xa Inhibitors; D011134:Polysaccharides; D014812:Vitamin K; D005337:Fibrin; D000077425:Fondaparinux; D010644:Phenprocoumon